NCT02977312 - Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions

Chronic Myeloid Leukemia, Chronic Phase

Interventions

DRUG

Imatinib

Observation of chronic myeloid leukemia (CML) patients in chronic phase (CP) treated with Cemivil

Trial Locations (3)

Al Bashir Hospital, Amman

Jordan University Hospital, Amman

King Hussein Cancer Center, Amman